Hanmi Science Sets Minimum 30% Total Shareholder Return Target by 2030... Accelerating Shareholder Value via Dividends, Buybacks, and RSUs
Announced a corporate value-up plan on Dec 4, 2025, targeting a minimum 30% total shareholder return (TSR) annually by 2030, including a minimum dividend system, share buybacks, and an employee RSU program.
Paid cash dividends for 9 consecutive years; 2025 dividend of 300 won per share (cash yield 0.8% on market price). Dividend amount was fixed on Mar 12, 2026, ahead of the record date (Mar 31, 2026), enhancing predictability. Payout ratios: consolidated 17.4%, standalone 50.2%.
Governance strengths include separation of board chair (outside director Choi Hyun-man) and CEO, a fully independent audit committee (3 outside directors), electronic voting, and avoiding concentrated AGM dates.
However, deficiencies exist: AGM notice less than 4 weeks (2 weeks), no formal CEO succession policy, and no individual evaluation of outside directors. The company plans to address these through internal process improvements and new regulations.
[AI Summary]Hanmi Science demonstrates commitment to shareholder value with a long-term 30% TSR target and consistent dividends, but governance gaps such as insufficient AGM notice, lack of CEO succession planning, and absence of outside director evaluations pose risks that require monitoring of progress.